Vor Biopharma VOR
NASDAQ VOR
$20.09 +0.53 (+2.71%)
At close: Nov 11, 2026 · 4:00 PM EST

Vor Biopharma (VOR) Change in Accrued Expenses (2020 - 2026)

Updated

Vor Biopharma's Change in Accrued Expenses came in at $11.51 million for Q3 2026, up 130.1% from $5 million a year earlier and up 30.7% from the prior quarter.

Analysis

Vor Biopharma (VOR) Change in Accrued Expenses (2020 - 2026) Analysis & Trends

Over the trailing twelve months to Sep 30, 2026, Vor Biopharma reported Change in Accrued Expenses of $17.42 million, up 107.1% year-over-year; for FY2025, it was $10.93 million, up 387.7% from FY2024.

  • Change in Accrued Expenses carries a five-year compound annual growth rate of 13.4% (FY2020 to FY2025).
  • Going back by year, Change in Accrued Expenses was $2.24 million in FY2024 (-21.4%), $2.85 million in FY2023 (+155.8%), $1.11 million in FY2022 (+175.1%) and $405,000 in FY2021 (-93.0%).
  • The Q3 2026 figure represents the highest quarterly Change in Accrued Expenses in data going back to Q1 2020.
  • The fastest year-over-year change in Change in Accrued Expenses over five years came in Q3 2025 (growth of 931.1%), and the weakest in Q4 2021 (a decline of 96.5%).
  • Business Quant data shows VOR's Change in Accrued Expenses at $8.8 million (Q2 2026), -$9.1 million (Q1 2026) and $6.21 million (Q4 2025) in the three quarters before Q3 2026.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Change Accrued Exp. (Qtr)
1 Eli Lilly 1,348.13 Bn 1,321.74 Bn 20.46 Bn -
2 Johnson & Johnson 675.90 Bn 595.76 Bn 17.30 Bn 2.41 Bn
3 AbbVie 519.45 Bn 487.50 Bn 13.12 Bn 983.00 Mn
4 Merck 364.95 Bn 327.95 Bn 13.19 Bn -
5 Novartis Ag 311.58 Bn 285.16 Bn - -
6 Astrazeneca 289.34 Bn 262.94 Bn 13.26 Bn -
7 Amgen 251.64 Bn 203.30 Bn 7.58 Bn -87.00 Mn
8 Gilead Sciences 212.05 Bn 187.07 Bn 6.73 Bn 756.00 Mn
9 Pfizer 167.35 Bn 115.00 Bn 12.56 Bn -
10 Vor Biopharma 1.20 Bn -692.85 Mn - 11.51 Mn
Historic Data

Historic Data

Download Data
DateValue
Sep 30, 2026 11.51 Mn
Jun 30, 2026 8.80 Mn
Mar 31, 2026 -9.10 Mn
Dec 31, 2025 6.21 Mn
Sep 30, 2025 5.00 Mn
Jun 30, 2025 1.10 Mn
Mar 31, 2025 -1.37 Mn
Dec 31, 2024 3.69 Mn
Sep 30, 2024 485,000.00
Jun 30, 2024 551,000.00
Mar 31, 2024 -2.48 Mn
Dec 31, 2023 172,000.00
Sep 30, 2023 2.66 Mn
Jun 30, 2023 107,000.00
Mar 31, 2023 -88,000.00
Dec 31, 2022 1.66 Mn
Sep 30, 2022 931,000.00
Jun 30, 2022 -751,000.00
Mar 31, 2022 -722,000.00
Dec 31, 2021 72,000.00
API Access

Vor Biopharma Change in Accrued Expenses API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=change-in-accured-expenses&ticker=VOR&period=max&api_key=YOUR_API_KEY